EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Genetic Spectrum of Large AIP Deletions

Tea Shehu Kolnikaj iD, Maren Ruka iD, Artur Xhumari iD, Anila Babameto-Laku iD, Athanasios Siolos, Panagiotis Alexandros Drakos iD, Kesson Magid iD, Thomas O Millner iD, Robert D Murray iD, Marinella Tzanela, Dragana Miljić iD, Arlinda Ramaj iD und 3 weitere

Human Mutation · 2026

DOI: 10.1155/humu/4212742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Tea Shehu Kolnikaj und 14 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, American Hospital, University of Medicine, Tirana, Albania, amerikanhastanesi.org. Hauptthemen laut MEDLINE: Intracellular Signaling Peptides and Proteins, Sequence Deletion. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Society of Endocrinology, Barts Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial isolated pituitary adenoma (FIPA) accounts for approximately 2%–5% of all pituitary adenomas, with inactivating variants of the aryl hydrocarbon receptor‐interacting protein ( AIP ) gene representing the most frequent known genetic cause. Clinically, patients with AIP variants often have young‐onset macroadenomas with growth hormone hypersecretion, although disease severity and penetrance are variable. Most reported AIP variants are point mutations, whereas large deletions are rare and potentially underdiagnosed. Accurate detection of AIP copy‐number variants requires methods such as multiplex ligation‐dependent probe amplification or validated copy‐number analysis of next‐generation sequencing data, as Sanger sequencing alone may fail to identify these alterations. Due to the rarity of the disease, it is unknown whether large deletions in the ubiquitously expressed AIP gene are associated with potentially more severe phenotype. Available data suggest that large deletions may occur in 8%–10% of AIP mutation‐positive pedigrees, highlighting the importance of incorporating copy‐number variant detection into AIP testing workflows. We analysed data from all published patients with large AIP deletions ( n = 25) and report here two novel large AIP deletions (Exons 3–4 and Exons 2–6 deletions) and three additional three families, including an Albanian kindred associated with metastatic Hürthle cell thyroid carcinoma. No major differences compared with other AIP variants were found in age at diagnosis, tumour size, hormonal profile, sex distribution or presence of other tumours. A role for AIP variants in thyroid carcinogenesis is unlikely.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracellular Signaling Peptides and ProteinsSequence DeletionHumansFemalePedigreeMaleDNA Copy Number VariationsAdultExonsPhenotypePituitary NeoplasmsMiddle AgedGenetic Association StudiesGrowth Hormone-Secreting Pituitary Adenoma

Stichwörter der Autor:innen

AIP geneHürthle cell thyroid carcinomaacromegalyfamilial isolated pituitary adenomagenetic mutation

Substanzen

aryl hydrocarbon receptor-interacting proteinIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Endocrinology, American Hospital, University of Medicine, Tirana, Albania, amerikanhastanesi.org.
  • Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy, uniroma1.it.
  • Neurosurgery, Faculty of Medicine, University of Medicine, Tirana, Albania, unito.it.
  • Genetics, Faculty of Medicine, University of Medicine Tirana, Tirana, Albania.
  • Department of Endocrinology, Ioannina University Hospital, Ioannina, Greece, uoi.gr.
  • Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK, qmul.ac.uk.

ORCID-Profile: Tea Shehu Kolnikaj, Maren Ruka, Artur Xhumari, Anila Babameto-Laku, Panagiotis Alexandros Drakos, Kesson Magid, Thomas O Millner, Robert D Murray, Dragana Miljić, Arlinda Ramaj, Paul Benjamin Loughrey, Stelios Tigas, Márta Korbonits

Förderung

  • European Society of Endocrinology
  • Barts Charity

Zitieren

APA

Kolnikaj, T. S., Ruka, M., Xhumari, A., Babameto-Laku, A., Siolos, A., Drakos, P. A., Magid, K., Millner, T. O., Murray, R. D., Tzanela, M., Miljić, D., Ramaj, A., Loughrey, P. B., Tigas, S., & Korbonits, M. (2026). Clinical and Genetic Spectrum of Large AIP Deletions. Human Mutation. https://doi.org/10.1155/humu/4212742

Vancouver

Kolnikaj TS, Ruka M, Xhumari A, Babameto-Laku A, Siolos A, Drakos PA, et al. Clinical and Genetic Spectrum of Large AIP Deletions. Human Mutation. 2026. doi:10.1155/humu/4212742

BibTeX
@article{Kolnikaj2026,
  author = {Kolnikaj, Tea Shehu and Ruka, Maren and Xhumari, Artur and Babameto-Laku, Anila and Siolos, Athanasios and Drakos, Panagiotis Alexandros and Magid, Kesson and Millner, Thomas O and Murray, Robert D and Tzanela, Marinella and Miljić, Dragana and Ramaj, Arlinda and Loughrey, Paul Benjamin and Tigas, Stelios and Korbonits, Márta},
  title = {Clinical and Genetic Spectrum of Large AIP Deletions},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/4212742}
}
Kostenlos starten →